过氧化物酶体增殖物激活受体δ诱导胰岛素诱导基因-1并抑制肥胖糖尿病小鼠的肝脏脂肪生成。 - Suppr | 超能文献

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.

作者信息

Sharma Rajeev, Torka Pallawi

出版信息

Hepatology. 2008 Dec;48(6):2085; author reply 2085-6. doi: 10.1002/hep.22602.

DOI:10.1002/hep.22602

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.过氧化物酶体增殖物激活受体δ诱导胰岛素诱导基因-1并抑制肥胖糖尿病小鼠的肝脏脂肪生成。

Hepatology. 2008 Dec;48(6):2085; author reply 2085-6. doi: 10.1002/hep.22602.

2

Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism.硬脂酰辅酶A去饱和酶1、固醇调节元件结合蛋白-1c和过氧化物酶体增殖物激活受体α：在脂质代谢调节中的独立及相互作用角色

Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):84-8. doi: 10.1097/01.mco.0000214564.59815.af.

3

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.过氧化物酶体增殖物激活受体δ诱导肥胖糖尿病小鼠的胰岛素诱导基因-1并抑制肝脏脂肪生成。

Hepatology. 2008 Aug;48(2):432-41. doi: 10.1002/hep.22334.

4

Aging is associated with a shift of fatty metabolism toward lipogenesis.衰老与脂肪代谢向脂肪生成转移有关。

J Gerontol A Biol Sci Med Sci. 2011 Nov;66(11):1192-200. doi: 10.1093/gerona/glr124. Epub 2011 Aug 10.

5

Fast break on the fat brake: mechanism of peroxisome proliferator-activated receptor-delta regulation of lipid accumulation in hepatocytes.脂肪酸刹车上的快速突破：过氧化物酶体增殖物激活受体δ调控肝细胞脂质积累的机制

Hepatology. 2008 Aug;48(2):355-7. doi: 10.1002/hep.22505.

6

Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).调节固醇调节元件结合蛋白（SREBPs）作为非酒精性脂肪性肝病（NAFLD）的潜在治疗方法。

Drug Discov Today. 2007 Sep;12(17-18):740-7. doi: 10.1016/j.drudis.2007.07.009. Epub 2007 Aug 27.

7

Liver lipid metabolism.肝脏脂质代谢。

J Anim Physiol Anim Nutr (Berl). 2008 Jun;92(3):272-83. doi: 10.1111/j.1439-0396.2007.00752.x.

8

Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.优格辛-A可预防高脂饮食喂养的C57BL/6J小鼠出现高血糖、高血脂和脂质过氧化。

J Pharm Pharmacol. 2009 Apr;61(4):517-25. doi: 10.1211/jpp/61.04.0015.

9

Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD-1 mice.尽管在糖尿病CD-1小鼠中肝胰岛素基因疗法具有胰岛素反应性转录效应，但仍会减少肝糖原。

J Gene Med. 2009 Jul;11(7):588-97. doi: 10.1002/jgm.1341.

10

SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.Krüppel样转录因子5的类泛素化修饰在涉及过氧化物酶体增殖物激活受体δ的脂质代谢转录程序中起分子开关的作用。

Nat Med. 2008 Jun;14(6):656-66. doi: 10.1038/nm1756. Epub 2008 May 25.

引用本文的文献

1

Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.肝 X 受体在乳腺炎治疗和乳脂合成调控中的作用。

J Mammary Gland Biol Neoplasia. 2019 Mar;24(1):73-83. doi: 10.1007/s10911-018-9403-5. Epub 2018 Jul 31.

2

PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.过氧化物酶体增殖物激活受体在肝脏疾病和癌症中的作用：miRNAs 的表观遗传调控。

PPAR Res. 2012;2012:757803. doi: 10.1155/2012/757803. Epub 2012 Sep 13.